222 related articles for article (PubMed ID: 11919229)
1. Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer.
Allegra CJ; Parr AL; Wold LE; Mahoney MR; Sargent DJ; Johnston P; Klein P; Behan K; O'Connell MJ; Levitt R; Kugler JW; Tria Tirona M; Goldberg RM
J Clin Oncol; 2002 Apr; 20(7):1735-43. PubMed ID: 11919229
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study.
Allegra CJ; Paik S; Colangelo LH; Parr AL; Kirsch I; Kim G; Klein P; Johnston PG; Wolmark N; Wieand HS
J Clin Oncol; 2003 Jan; 21(2):241-50. PubMed ID: 12525515
[TBL] [Abstract][Full Text] [Related]
3. Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy.
Edler D; Glimelius B; Hallström M; Jakobsen A; Johnston PG; Magnusson I; Ragnhammar P; Blomgren H
J Clin Oncol; 2002 Apr; 20(7):1721-8. PubMed ID: 11919227
[TBL] [Abstract][Full Text] [Related]
4. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
[TBL] [Abstract][Full Text] [Related]
6. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
Kamoshida S; Matsuoka H; Ishikawa T; Maeda K; Shimomura R; Inada K; Tsutsumi Y
Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457
[TBL] [Abstract][Full Text] [Related]
9. A combined analysis of mismatch repair status and thymidylate synthase expression in stage II and III colon cancer.
Öhrling K; Karlberg M; Edler D; Hallström M; Ragnhammar P
Clin Colorectal Cancer; 2013 Jun; 12(2):128-35. PubMed ID: 23276521
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses.
Etienne MC; Chazal M; Laurent-Puig P; Magné N; Rosty C; Formento JL; Francoual M; Formento P; Renée N; Chamorey E; Bourgeon A; Seitz JF; Delpero JR; Letoublon C; Pezet D; Milano G
J Clin Oncol; 2002 Jun; 20(12):2832-43. PubMed ID: 12065560
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer.
Aguiar S; Lopes A; Soares FA; Rossi BM; Ferreira FO; Nakagawa WT; Carvalho AL; Filho WJ
Eur J Surg Oncol; 2005 Oct; 31(8):863-8. PubMed ID: 15923105
[TBL] [Abstract][Full Text] [Related]
12. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer.
Johnston PG; Fisher ER; Rockette HE; Fisher B; Wolmark N; Drake JC; Chabner BA; Allegra CJ
J Clin Oncol; 1994 Dec; 12(12):2640-7. PubMed ID: 7989939
[TBL] [Abstract][Full Text] [Related]
13. Thymidylate synthase and p53 expression in primary tumor do not predict chemotherapy outcome in metastatic colorectal carcinoma.
Berglund A; Edler D; Molin D; Nordlinder H; Graf W; Glimelius B
Anticancer Res; 2002; 22(6B):3653-9. PubMed ID: 12552972
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer.
van Triest B; Pinedo HM; Blaauwgeers JL; van Diest PJ; Schoenmakers PS; Voorn DA; Smid K; Hoekman K; Hoitsma HF; Peters GJ
Clin Cancer Res; 2000 Mar; 6(3):1063-72. PubMed ID: 10741735
[TBL] [Abstract][Full Text] [Related]
15. Low thymidylate synthase expression in the primary tumor predicts favorable clinical outcome in resected gastric cancer patients treated with adjuvant tegafur.
Grau JJ; Domingo-Domenech J; Morente V; Pera M; Garcia-Valdecasas JC; Fuster J; Bombí A; Mellado B; Albanell J; Gascón P
Oncology; 2004; 66(3):226-33. PubMed ID: 15218314
[TBL] [Abstract][Full Text] [Related]
16. Thymidylate synthase expression in normal colonic mucosa: a predictive marker of toxicity in colorectal cancer patients receiving 5-fluorouracil-based adjuvant chemotherapy.
Santini D; Vincenzi B; Perrone G; Rabitti C; Borzomati D; Caricato M; La Cesa A; Grilli C; Verzì A; Coppola R; Tonini G
Oncology; 2004; 67(2):135-42. PubMed ID: 15539918
[TBL] [Abstract][Full Text] [Related]
17. [Morphological assessment of predictive factors in adenocarcinoma of the colon].
Raskin GA; Pozharisskiĭ KM; Orlova RV
Vopr Onkol; 2014; 60(5):619-24. PubMed ID: 25816668
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of thymidylate synthase expression in bladder cancer.
Nomura T; Nakagawa M; Fujita Y; Hanada T; Mimata H; Nomura Y
Int J Urol; 2002 Jul; 9(7):368-76. PubMed ID: 12165018
[TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthase expression in stage II and III colon cancer: a retrospective review.
Tomiak A; Vincent M; Earle CC; Johnston PG; Kocha W; Taylor M; Maroun J; Eidus L; Whiston F; Stitt L
Am J Clin Oncol; 2001 Dec; 24(6):597-602. PubMed ID: 11801762
[TBL] [Abstract][Full Text] [Related]
20. A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803.
Niedzwiecki D; Hasson RM; Lenz HJ; Ye C; Redston M; Ogino S; Fuchs CS; Compton CC; Mayer RJ; Goldberg RM; Colacchio TA; Saltz LB; Warren RS; Bertagnolli MM
Oncologist; 2017 Jan; 22(1):107-114. PubMed ID: 27821793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]